Elucidating the precise pharmacological mechanism of action (MOA) of naturally occurring compounds could be tough. Even though Tarselli et al. (60) created the initial de novo synthetic pathway to conolidine and showcased this naturally occurring compound proficiently suppresses responses to both chemically induced and inflammation-derived pain, the pharmacologic target https://www.proleviate.com/post/conolidine-an-alternative-natural-pain-relief-to-replace-traditional-painkillers